First, the reversal of epigenetic silencing, potentially through the use of DNA methyltransferase inhibitors (Nunes and Henrique, 2020), could restore the expression of tumor suppressor metabolic hubs such as FBP1 and HPGD, thereby rebalancing cellular metabolism and limiting tumor progression. This evidence concerns the gene HPGD and neoplasm.